December 19, 2007
FDA to Review Long Acting Form of Zyprexa
Posted at December 19, 2007 8:42 PM in .
Zyprexa, the schizophrenia and bipolar drug manufactured by Eli Lilly, is now being considered in an injectable form every two to three weeks. The injection would be administered in a doctor's office. In spite of the drug's association with diabetes, the main concern with the longer acting form of the drug is a severe form of sleepiness.
Trackback
You can ping this entry by using http://www.saundersblog.com/cgi-bin/mt/mt-tb.cgi/465 .